Article Text

Download PDFPDF

Carotid endarterectomy for treatment of carotid in-stent restenosis: long-term follow-up results and surgery experiences from one single centre
  1. Le-Bao Yu1,2,3,4,
  2. Wei Yan5,
  3. Qian Zhang1,2,3,4,
  4. Ji-Zong Zhao1,2,3,4,
  5. Yan Zhang1,2,3,4,
  6. Rong Wang1,2,3,4,
  7. Jun-Shi Shao1,2,3,4,
  8. Dong Zhang1,2,3,4
  1. 1 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  2. 2 China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China
  3. 3 Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
  4. 4 Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
  5. 5 Department of Neurosurgery, Beijing Mi Yun Hospital, Capital Medical University, Beijing, China
  1. Correspondence to Professor Dong Zhang; zhangdong0660{at}163.com

Abstract

Objective Few studies have reported the surgical treatment of carotid in-stent restenosis (ISR), more data and longer follow-up are needed. We describe the surgical treatment of ISR by standard carotid endarterectomy (CEA) with stent removal, including long-term follow-up in 10 patients from our centre.

Methods Ten patients from our centre who underwent CEA with stent removal for ISR were retrospectively analysed, including nine symptomatic and one asymptomatic ISR of at least 70% with mean age 67.3, the median time between carotid artery stenting and CEA was 17 months (range, 2–54 months).

Results Standard CEA with stent removal was performed in all 10 patients without much technical difficulty (9 male and 1 female, mean age 67.3). Two cases were performed in hybrid operation room. There were a total of three complications that happened in three patients (30%) respectively. An asymptomatic dissecting aneurysm was formed on the petrous internal carotid artery in one patient who was followed up without intervention. In the second case, dissection occurred in the arterial wall distal to the site of the stent after stent removal revealed by intraoperative angiography, and another stent was implanted. The patient sustained temporary hypoglossal nerve dysfunction postoperatively. The third patient suffered cerebral hyperperfusion with complete recovery when discharged. No neurological complications occurred in other seven patients. After follow-up of 25 months (range, 11–54 months), one patient died of rectal cancer without ischaemic attack and restenosis 4 years postoperation; in one patient occurred recurrent symptomatic restenosis (90%) 1 year later; all other patients remained asymptomatic and without recurrent restenosis (>50%) by follow-up carotid ultrasound or CT angiography.

Conclusion It seems that CEA with stent removal is a reasonable choice, by experienced hand, for symptomatic ISR with higher but acceptable complications. The indication of stent removal for asymptomatic ISR needs further observation.

  • Carotid endarterectomy (CEA)
  • In-stent restenosis (ISR)
  • Carotid artery stenting (CAS)
  • Stent removal

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors All of the coauthors meet the criteria for authorship and are responsible for specific parts of this work. LBY, WY, QZ, MMJSS: conception or design of the work; the acquisition, analysis or interpretation of data for the work. JZZ, YZ, RW, DZ: revising the paper critically for important intellectual content.

  • Funding The China National Clinical Research Center for Neurosurgical Diseases (NCRC-ND)(2015BAI12B04); The Program of the National Natural Science Foundation of China (81371292).

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval The Ethics Committee of Tiantan Hospital.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles